> ## Content Index
> Fetch the complete content index at: https://www.bullished.co/llms.txt
> Use this file to discover other available public pages before exploring further.

# Enovix's Debt Value Falls To $190.2 Million From $292.3 Million
- URL: https://www.bullished.co/enovixs-debt-value-falls-to-190-2-million-from-292-3-million-4c150bcf/
- Published: 2026-11-13T11:36:09.000Z
- Updated: 2026-11-16T16:20:28.000Z
- Description: Discounted buybacks cancelled debt, but a separate warrant offer leaves the next repayment bill dependent on holders' choices.
- Author: Matteo Parrino
- Tags: SEC Filings, ENVX, Industry: Industrials

[Enovix](https://www.bullished.co/tag/envx/), which designs and makes lithium-ion batteries, estimated its 2030 convertible debt was worth approximately [$190.2 million](https://www.sec.gov/Archives/edgar/data/0001828318/000182831826000072/envx-20261004.htm?ref=bullished.co) on October 4, down from approximately $292.3 million on July 5\. Friday's quarterly filing put the principal owed at $360 million at quarter-end: a lower valuation alone does not cancel the repayment obligation.

## A Discount Becomes Actual Debt Relief

The [previous quarterly filing](https://www.sec.gov/Archives/edgar/data/0001828318/000182831826000056/envx-20260705.htm?ref=bullished.co) valued the same $360 million principal at approximately $292.3 million on July 5\. Enovix said the notes are not actively traded, and it uses observable market inputs to estimate their value.

Enovix turned some of that discount into debt relief through purchases in October and November. It retired [$128 million](https://www.sec.gov/Archives/edgar/data/0001828318/000182831826000069/enovixq32026financialres.htm?ref=bullished.co) of principal for approximately $81.4 million in cash, plus accrued interest, as already described in Thursday's earnings release. The company put the discount at approximately 36%, leaving $232 million of the 2030 notes outstanding.

October's purchase cancelled $100 million of principal for approximately $63.1 million. November's purchase cancelled another $28 million for approximately $18.3 million. Those purchases changed what Enovix owes; the quarter-end fair-value estimate measured what the debt was worth.

The remaining notes carry a 4.75% annual interest rate and mature on September 15, 2030, unless converted, redeemed or bought back earlier.

## The $172.5 Million Holder Decision

Enovix's nearer repayment obligation is a separate $172.5 million convertible issue carrying 3.00% annual interest. Those notes mature on May 1, 2028, and the company is offering holders a route to exchange them for stock.

Enovix expects to distribute approximately [61 million warrants](https://www.sec.gov/Archives/edgar/data/0001828318/000182831826000072/envx-20261004.htm?ref=bullished.co)—rights to buy shares—on or about Wednesday. Stockholders receive one warrant for every four shares, rounded down to a whole warrant. Holders of both convertible issues also receive warrants based on the shares their notes could convert into, without first converting the debt.

Each warrant initially allows its holder to buy a share for $3.00\. Payment can come in cash or through surrendering 2028 notes credited at face value. Cash exercises add money to Enovix; note-funded exercises cancel the surrendered debt.

Holders can exercise, sell or keep their warrants. Enovix warned that their choices determine both the cash it receives and the debt it retires. Exercises increase the share count, diluting holders who neither exercise nor sell their rights.

The warrants are scheduled to expire April 28, 2028, with earlier expiration possible under specified conditions. Enovix would have to repay or refinance any 2028 principal still outstanding at maturity. It is also evaluating how to account for the warrants.

## Cash Must Fund More Than Buybacks

Enovix has previously used warrants to bring in capital: its 2025 program generated [$232.1 million](https://www.sec.gov/Archives/edgar/data/0001828318/000182831826000056/envx-20260705.htm?ref=bullished.co) in gross proceeds. The latest offer can produce either fresh cash or cancelled debt, depending on how holders pay.

The company had $512.2 million in cash, cash equivalents, restricted cash and investments on October 4\. That balance preceded the subsequent note purchases and October stock buybacks, which used approximately $96.9 million in aggregate, excluding accrued interest on November's note purchase.

Stock repurchases themselves used approximately $6.2 million in the third quarter and another $15.5 million in October. Operations consumed $84.1 million through October 4, compared with $68.3 million in the corresponding prior-year period.

Management expects its cash to cover funding needs for the next twelve months from Friday's filing. Its stated priorities include operations, South Korean capacity and selected product development.

## Korean Capacity Competes For Cash

Enovix sells cells and battery packs for consumer devices, drones, defense and industrial uses. It is focusing silicon-anode development on smaller batteries for smart eyewear and similar devices, while its South Korean operations serve drone, defense and industrial customers.

The company is spending approximately $19 million on a South Korean expansion it expects to double drone battery capacity in mid-2027\. It expects fourth-quarter capital spending of $5 million to $8 million, principally for that project.

In November, Enovix eliminated approximately 220 of 946 employee and contract direct-labor positions, mostly in Malaysia, with smaller cuts in the United States, India and China. It expects approximately $8.5 million in annualized pay-and-benefit savings and approximately $1.5 million in fourth-quarter restructuring charges.

Ryan Benton, Enovix's interim chief executive officer, said in Thursday's release: "We are thus concentrating our silicon-anode development on smart eyewear and [restructuring to direct](https://www.sec.gov/Archives/edgar/data/0001828318/000182831826000069/enovixq32026financialres.htm?ref=bullished.co) more resources toward our operations in Korea."

Wednesday's expected warrant distribution gives holders the choice of adding cash or cancelling 2028 debt. Enovix still owes whatever principal they leave outstanding.

### Sources

- [10-Q Filing — Enovix (ENVX)](https://www.sec.gov/Archives/edgar/data/0001828318/000182831826000072/envx-20261004.htm?ref=bullished.co) — SEC EDGAR
- [10-Q Filing — Enovix (ENVX), Q2 FY2026 filed 2026-08-12](https://www.sec.gov/Archives/edgar/data/0001828318/000182831826000056/envx-20260705.htm?ref=bullished.co) — SEC EDGAR
- [Earnings release (8-K Item 2.02, enovixq32026financialres.htm) — Enovix, filed 2026-11-12](https://www.sec.gov/Archives/edgar/data/0001828318/000182831826000069/enovixq32026financialres.htm?ref=bullished.co) — SEC EDGAR
- [Enovix Corp. (NasdaqGS:ENVX) : Articles :: Law360](https://www.law360.com/companies/enovix-corp?article%5Frelated%5Fcontent=1&ref=bullished.co) — law360.com
- [Drones Drive Strong ENVX Revenue Growth](https://www.globenewswire.com/news-release/2026/11/12/3401472/0/en/drones-drive-strong-envx-revenue-growth.html?ref=bullished.co) — globenewswire.com
- [Lost Money on Enovix Corporation Stock? Glancy Prongay Wolke & Rotter LLP Investigates Possible Securities Fraud After 28.66% Share Price Drop](https://www.businesswire.com/news/home/20261112926177/en/Lost-Money-on-Enovix-Corporation-Stock-Glancy-Prongay-Wolke-Rotter-LLP-Investigates-Possible-Securities-Fraud-After-28.66-Share-Price-Drop?ref=bullished.co) — businesswire.com
- [ENVX DOWN 14%: Enovix Investigated for Securities Fraud;](https://www.globenewswire.com/news-release/2026/11/12/3401878/0/en/envx-down-14-enovix-investigated-for-securities-fraud-investors-should-contact-block-leviton-to-possibly-recover-losses.html?ref=bullished.co) — globenewswire.com

### More on Enovix

- [Enovix Puts Paying Eyewear Orders Ahead Of Smartphone Testing Despite Nearing Qualification](https://www.bullished.co/enovix-puts-paying-eyewear-orders-ahead-of-smartphone-testing-despite-nearing-f40cc3e3/)
- [Enovix Stock Falls 21% After A Forecast Of Lower Sales And The Cancellation Of Planned Smartphone Tests](https://www.bullished.co/enovix-stock-falls-21-after-a-forecast-of-lower-sales-and-the-cancellation-of-planned-2c6f3792/)
- [Enovix Puts Eyewear Ahead Of Smartphones And Forecasts $65 Million To $85 Million Sales](https://www.bullished.co/enovix-puts-eyewear-ahead-of-smartphones-and-forecasts-65-million-to-85-million-sales-9527a586/)

[All Enovix (ENVX) coverage →](https://www.bullished.co/tag/envx/)